Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
Article
[키워드] acute respiratory syndrome
Against
Analysis
approved
bioinformatics
caused
Clinical characteristics
Clinical data
contagious
coronavirus
Coronavirus disease 2019
correlation
country
COVID-19
COX
Cytoscape
downloaded
drug
drug target
DrugBank
evaluate
evaluated
Fatality rate
FDA
Features
food
functional
Gene Expression
GeneCards
Genes
GO enrichment analysis
IL-17
IL12B
IL6
include
infected with COVID-19
Interaction
KEGG
LBP
lung adenocarcinoma (LUAD)
lung cancer patient
management
mechanism
modulate
molecular
molecular docking
Mortality
NCBI
network
network pharmacology
pandemic
pathway
Pathway analysis
Patient
Paxlovid
Pharmacology
Potential
potential therapeutic target
Prognosis
prognostic
receptor
Regression model
risk
SARS-CoV-2
screened
signaling pathway
survival rate
susceptibility
SwissTargetPrediction
target
target gene
TargetNet
therapeutic target
Transcriptome
Treatment
Venn diagram
virus
was performed
was used
while
[DOI] 10.3389/fendo.2022.935906 PMC 바로가기
[DOI] 10.3389/fendo.2022.935906 PMC 바로가기